Status:
ENROLLING_BY_INVITATION
Multiple Sclerosis: FutureMS-2 - an Observational Cohort and Scottish Precision Medicine Study
Lead Sponsor:
University of Edinburgh
Collaborating Sponsors:
NHS Lothian
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
FutureMS is a project created in direct response to frequent questions people with MS ask their doctors. Every person newly diagnosed wants to know how MS will affect them over their life and what can...
Detailed Description
MS is a chronic incurable and devastating inflammatory - neurodegenerative disorder of the central nervous system. There are an estimated 2.4M people with multiple sclerosis (pwMS). Scotland has one o...
Eligibility Criteria
Inclusion
- Previous participants in FutureMS cohort
- Capacity to provide informed consent
Exclusion
- Not a participant of FutureMS inception cohort
- Contraindication to MR brain imaging
Key Trial Info
Start Date :
October 7 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2029
Estimated Enrollment :
440 Patients enrolled
Trial Details
Trial ID
NCT06001138
Start Date
October 7 2021
End Date
September 1 2029
Last Update
May 11 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Aberdeen Clinical Research Facility Royal Cornhill Hospital
Aberdeen, United Kingdom, AB25 2ZD
2
Dundee Clinical Research Centre Ninewells Hospital
Dundee, United Kingdom, DD1 9SY
3
Anne Rowling Regenerative Neurology Clinic
Edinburgh, United Kingdom, EH16 4SB
4
Glasgow Clinical Research Facility Queen Elizabeth University Hospital
Glasgow, United Kingdom, G51 4TF